囊收缩管理:没有脚手架的治疗
Orr Shauly1, Albert Losken1, Alexa Clark2
1Division of Plastic and Reconstructive Surgery, Emory University, Atlanta, GA, USA.
Clinics in plastic surgery
|March 13, 2026
概括
囊收缩 (CC) 是乳房重建后的常见并发症,通常需要重新手术. 了解其原因和风险因素对于改善患者的治疗结果和尽量减少手术风险至关重要.
科学领域:
- 整形外科 整形外科 整形外科
- 重建性手术是一种重建性手术.
- 生物材料科学 生物材料科学
背景情况:
- 囊收缩 (CC) 是乳房重建后的一个重大并发症,经常需要修复手术.
- 结核病的病因被认为是多因素的,在科学文献中提出了各种理论.
- 一些可修改的风险因素有助于CC的发展.
研究的目的:
- 审查目前对乳房重建中的囊收缩 (CC) 的理解.
- 讨论CC的潜在原因,风险因素和管理策略.
- 为了比较不同手术技术的疗效和风险,用于CC.
主要方法:
- 关于乳房重建中的囊收缩症的同行评审文章的文献综述.
- 对当前关于CC多因素原因的理论进行分析.
- 评估手术干预措施,如囊切除和囊切除.
主要成果:
- 囊收缩 (CC) 是乳房重建中重新手术的主要驱动因素.
- 囊切除术通常比囊切除术更受青,因为手术时间更短,恢复速度更快,特别是在较薄的囊中.
- 虽然囊切除术是既定的标准,但与囊切除术相比,它具有更高的风险.
结论:
- 囊收缩 (CC) 的有效管理对于成功的乳房重建结果至关重要.
- 像囊切割这样的外科手术技术为CC管理提供了潜在的不那么侵入性的方法.
- 对于CC的重新运行,尽管有审美益处,但涉及固有的风险,包括出血和建筑扭曲.
相关概念视频
Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
Flail Chest-II
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
Chest Physiotherapy
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...


